Resistance Training in Patients With Morbid Obesity (ExinMO)
Preventing Metabolic Syndrome in Patients With Morbid Obesity by Resistance Training: Reporting Non-responder Prevalence
연구 개요
상세 설명
The prevalence of metabolic syndrome (MetS) and cardiovascular disease is expected to rise along with the global obesity epidemic. MetS is a cluster of clinical risk factors, including abdominal (visceral) obesity, hypertension, elevated serum triglycerides, low serum high-density lipoprotein (HDL) and hyperglycaemia.The MetS for example, significantly decreases the life expectancy of individuals with morbid obesity and increases the disease burden and economic costs associated with healthcare. In this sense, more recently, there was reported that body mass index (BMI) and fat distribution showed higher associations with inflammation, fat indices, and more prevalence of MetS in morbidly obese subjects, claiming for an early prevention of the MetS in the morbid obese state.
Exercise training has proven to be effective in inducing a clinically significant weight loss and reducing cardiovascular risk. Exercise have reported to be associated with increased muscle mass, decreased body fat, and improved metabolic profile (i.e., improved glucose control and lipid levels). In addition, supervised RT improved muscle strength and functional capacity in patients with obesity undergoing bariatric surgery. However, although RT has been widely studied in obesity, there is little information in the morbid obesity. On the other hand, there is poor knowledge similarly, about the interindividual variability to exercise training in terms of responders and non-responders (NR). Thus, considering the poor knowledge about the MetS prevention in morbid obese patients, as well as the little information about Responders and Non-Responders for improving MetS outcomes, the aim of this study will be determine the effects of a RT program on cardio-metabolic outcomes of MetS in patients with morbid obesity. A second aim will be report the prevalence of non-responders in terms of the effects of resistance training on MetS markers and other health-related variables.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Llanquihue
-
Osorno, Llanquihue, 칠레, 5290000
- Cristian ALvarez
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
Inclusion Criteria:
- Older than 18 and younger and ≤65 years of age.
- With risk factors to Metabolic syndrome
- With obesity and morbid obesity condition
- Medical authorization by a physician.
Exclusion Criteria:
- Physical limitations (e.g., restricting injuries of the musculoskeletal system, or dependent of a third person).
- Exercise-related dyspnoea or respiratory alterations.
- Chronic heart disease with any worsening in the last month.
- Adherence rate of less than 80% of the total interventions.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위화되지 않음
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: Active comparator
Control group with obesity under Resistant Training
|
The 20-week RT program will consist of three sessions per week, each lasting for 1 hour that will be applied to both control obese (CG) and morbid obese (MO) group.
All sessions will start with 15 minutes warm-up with continuous walking and joint mobility and flexibility exercises, 5 minutes of cool down and stretching, in order for preventing injuries.
Sessions will include 4 to 8 RT exercises targeting different muscle groups; 1. forearm, 2. knee flexors and 3. extensors, 3. trunk, 4. chest, 5. shoulder elevators, 6. horizontal shoulder flexors and 7. extensors, and 8. plantar flexors.
The exercises for each muscle group will be performed in 3 sets of as many repetitions (continuous concentric/eccentric voluntary contraction) possible in 1 minute followed by 2.0 minutes of passive recovery.
Before the RT program, each participant will be measure using the subjective modified Borg scale (1-10 points), in order of identifying the muscle failure into 1 minute of exercise.
다른 이름들:
|
|
실험적: Experimental group with morbid obesity
Experimental group with morbid obesity under Resistant Training
|
The 20-week RT program will consist of three sessions per week, each lasting for 1 hour that will be applied to both control obese (CG) and morbid obese (MO) group.
All sessions will start with 15 minutes warm-up with continuous walking and joint mobility and flexibility exercises, 5 minutes of cool down and stretching, in order for preventing injuries.
Sessions will include 4 to 8 RT exercises targeting different muscle groups; 1. forearm, 2. knee flexors and 3. extensors, 3. trunk, 4. chest, 5. shoulder elevators, 6. horizontal shoulder flexors and 7. extensors, and 8. plantar flexors.
The exercises for each muscle group will be performed in 3 sets of as many repetitions (continuous concentric/eccentric voluntary contraction) possible in 1 minute followed by 2.0 minutes of passive recovery.
Before the RT program, each participant will be measure using the subjective modified Borg scale (1-10 points), in order of identifying the muscle failure into 1 minute of exercise.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Fasting glucose
기간: Change from Baseline Fasting glucose at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline Fasting glucose at 20-weeks of Resistant Training
|
|
High density lipoprotein
기간: Change from Baseline High density lipoprotein at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline High density lipoprotein at 20-weeks of Resistant Training
|
|
Systolic blood pressure and diastolic blood pressure
기간: from Baseline Systolic blood pressure and diastolic blood after 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
from Baseline Systolic blood pressure and diastolic blood after 20-weeks of Resistant Training
|
|
Waist circumference
기간: Change from Baseline Waist circumference at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline Waist circumference at 20-weeks of Resistant Training
|
|
Triglycerides
기간: Change from Baseline Triglycerides at 20-weeks of Resistant Training
|
Component of the Metabolic Syndrome
|
Change from Baseline Triglycerides at 20-weeks of Resistant Training
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Body mass index
기간: Change from Baseline Body mass index at 20-weeks of Resistant Training
|
Anthropometric
|
Change from Baseline Body mass index at 20-weeks of Resistant Training
|
|
Body mass
기간: Change from Baseline Body mass at 20-weeks of Resistant Training
|
Anthropometric
|
Change from Baseline Body mass at 20-weeks of Resistant Training
|
|
Total cholesterol
기간: Change from Baseline Total cholesterol at 20-weeks of Resistant Training
|
Measured by plasma sample
|
Change from Baseline Total cholesterol at 20-weeks of Resistant Training
|
|
Low density lipoprotein
기간: Change from Baseline Low density lipoprotein at 20-weeks of Resistant Training
|
Measured by plasma sample
|
Change from Baseline Low density lipoprotein at 20-weeks of Resistant Training
|
|
Six minutes walking test
기간: Change from Baseline Six minutes walking test density lipoprotein at 20-weeks of Resistant Training
|
Endurance performance
|
Change from Baseline Six minutes walking test density lipoprotein at 20-weeks of Resistant Training
|
|
One maximum repetition of biceps curl
기간: Change from Baseline One maximum repetition of biceps curl at 20-weeks of Resistant Training
|
Strength Performance
|
Change from Baseline One maximum repetition of biceps curl at 20-weeks of Resistant Training
|
|
Handgrip muscle strength
기간: Change from Baseline Handgrip muscle strength at 20-weeks of Resistant Training
|
Muscle strength
|
Change from Baseline Handgrip muscle strength at 20-weeks of Resistant Training
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Cristian ALvarez, PhD, Universidad de Los Lagos
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- RP08042019
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .